Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Vapotherm, Inc. (VAPO)

1.35   0.02 (1.5%) 01-27 16:00
Open: 1.31 Pre. Close: 1.33
High: 1.54 Low: 1.32
Volume: 227,378 Market Cap: 36(M)

Technical analysis

as of: 2023-01-27 4:48:58 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 2.71     One year: 3.45
Support: Support1: 1.29    Support2: 1.08
Resistance: Resistance1: 2.32    Resistance2: 2.96
Pivot: 1.77
Moving Average: MA(5): 1.39     MA(20): 2
MA(100): 1.58     MA(250): 4.52
MACD: MACD(12,26): -0.2     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 1.8     %D(3): 2.4
RSI: RSI(14): 36
52-week: High: 17.7  Low: 0.46
Average Vol(K): 3-Month: 690 (K)  10-Days: 193 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ VAPO ] has closed above bottom band by 21.5%. Bollinger Bands are 21.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.54 - 1.55 1.55 - 1.56
Low: 1.29 - 1.3 1.3 - 1.31
Close: 1.34 - 1.35 1.35 - 1.36

Company Description

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Headline News

Mon, 23 Jan 2023
Should Medical Devices Stock Vapotherm Inc (VAPO) Be in Your Portfolio Monday? - InvestorsObserver

Sat, 31 Dec 2022
Vapotherm Stock: Struggling For Air (NYSE:VAPO) - Seeking Alpha

Tue, 20 Dec 2022
Healthcare Stocks Moving Tuesday: ICCM, ATNF, VRNA, VAPO, BIVI, RCUS, SLNO, BYSI - InvestorsObserver

Wed, 07 Dec 2022
How Does Vapotherm Inc (VAPO) Stock Rank on Wall Street Wednesday? - InvestorsObserver

Fri, 02 Dec 2022
Vapotherm (VAPO) Stock Surged 51.69%: Details - Pulse 2.0

Sat, 05 Nov 2022
Vapotherm, Inc. (VAPO) Q3 2022 Earnings Call Transcript - Seeking Alpha

Financial Analysis

Price to Book Value: Underperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 26 (M)
Shares Float 16 (M)
% Held by Insiders 10.5 (%)
% Held by Institutions 58.1 (%)
Shares Short 317 (K)
Shares Short P.Month 360 (K)

Stock Financials

EPS -2.17
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.42
Profit Margin (%) -103
Operating Margin (%) -78.9
Return on Assets (ttm) -30.3
Return on Equity (ttm) -182.8
Qtrly Rev. Growth -37.1
Gross Profit (p.s.) 2.04
Sales Per Share 3.64
EBITDA (p.s.) -2.66
Qtrly Earnings Growth 0
Operating Cash Flow -75 (M)
Levered Free Cash Flow -59 (M)

Stock Valuations

PE Ratio -0.63
PEG Ratio -0.1
Price to Book value 0.3
Price to Sales 0.37
Price to Cash Flow -0.47

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.